---
title: "CannaPharmaRX, Inc. (CPMD.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CPMD.US.md"
symbol: "CPMD.US"
name: "CannaPharmaRX, Inc."
industry: "Pharmaceuticals"
---

# CannaPharmaRX, Inc. (CPMD.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.cannapharmarx.com](https://www.cannapharmarx.com) |

## Company Profile

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Canada. It produces and sells dried cannabis flower. The company is based in Calgary, Canada.

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-18T04:30:13.000Z

**Overall: C (0.58)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 106 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 404.63% |  |
| Net Profit YoY | -630.62% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -0.09 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.97M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.71M |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 36.29% | A |
| Profit Margin | -429.32% | E |
| Gross Margin | -67.01% | E |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 404.63% | A |
| Net Profit YoY | -630.62% | E |
| Total Assets YoY | -0.55% | D |
| Net Assets YoY | -35.77% | E |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -23.29% | D |
| OCF YoY | 404.63% | A |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.15 | D |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 293.83% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - CannaPharmaRX, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "36.29%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-429.32%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "-67.01%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "404.63%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-630.62%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.55%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-35.77%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-23.29%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "404.63%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.15",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "293.83%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Eli Lilly (US.LLY) | A | A | B | E | B | B |
| 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B |
| 03 | Roche (US.RHHBY) | A | B | B | D | C | B |
| 04 | AstraZeneca (US.AZN) | A | B | C | D | C | B |
| 05 | NOVARTIS AG (US.NVS) | A | B | C | D | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.27 | 76/256 | 2.66 | 2.29 | 1.88 |
| PB | -0.09 | 197/256 | - | - | - |
| PS (TTM) | 1.15 | 37/256 | 3.52 | 2.12 | 1.45 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/CPMD.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CPMD.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CPMD.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.